|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 692.68 USD | +2.80% |
|
+4.56% | +23.33% |
| 10-28 | Medpace Holdings Insider Sold Shares Worth $13,540,000, According to a Recent SEC Filing | MT |
| 10-23 | Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says | MT |
Company Valuation: Medpace Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,822 | 6,606 | 9,405 | 10,326 | 15,821 | 19,375 | - | - |
| Change | - | -15.54% | 42.38% | 9.79% | 53.21% | 22.47% | - | - |
| Enterprise Value (EV) 1 | 7,361 | 6,767 | 9,302 | 9,657 | 15,324 | 18,564 | 18,103 | 17,580 |
| Change | - | -8.07% | 37.47% | 3.81% | 58.68% | 21.14% | -2.48% | -2.89% |
| P/E | 45.2x | 29.2x | 34.5x | 26.3x | 36.8x | 38x | 35.3x | 31.6x |
| PBR | 8.61x | 18.5x | 17.5x | 12.9x | 35.3x | 28.6x | 22.7x | 17.9x |
| PEG | - | 0.6x | 1.6x | 0.6x | 1.8x | 2x | 4.63x | 2.7x |
| Capitalization / Revenue | 6.85x | 4.52x | 4.99x | 4.9x | 6.25x | 6.8x | 6.41x | 5.91x |
| EV / Revenue | 6.44x | 4.63x | 4.93x | 4.58x | 6.06x | 6.51x | 5.99x | 5.36x |
| EV / EBITDA | 33x | 22x | 25.7x | 20.1x | 27.5x | 28.7x | 26.5x | 23.5x |
| EV / EBIT | 35.5x | 23.7x | 27.5x | 21.4x | 28.9x | 30x | 27.6x | 24.4x |
| EV / FCF | 31.3x | 19.3x | 23.4x | 16.9x | 22.5x | 29.4x | 29.6x | 21.2x |
| FCF Yield | 3.19% | 5.19% | 4.26% | 5.93% | 4.45% | 3.4% | 3.38% | 4.72% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.81 | 7.28 | 8.88 | 12.63 | 15.28 | 18.23 | 19.62 | 21.89 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,142 | 1,460 | 1,886 | 2,109 | 2,530 | 2,850 | 3,021 | 3,279 |
| EBITDA 1 | 223.1 | 308.1 | 362.5 | 480.2 | 557.7 | 647.5 | 683.9 | 749.3 |
| EBIT 1 | 207.1 | 285.8 | 338.4 | 450.9 | 529.6 | 619.8 | 655.6 | 720.2 |
| Net income 1 | 181.8 | 245.4 | 282.8 | 404.4 | 451.1 | 520.5 | 553.7 | 610.6 |
| Net Debt 1 | -461.3 | 160.6 | -103.3 | -669.4 | -497 | -811.7 | -1,272 | -1,795 |
| Reference price 2 | 217.64 | 212.41 | 306.53 | 332.23 | 561.65 | 692.68 | 692.68 | 692.68 |
| Nbr of stocks (in thousands) | 35,939 | 31,100 | 30,683 | 31,082 | 28,168 | 27,972 | - | - |
| Announcement Date | 2/14/22 | 2/13/23 | 2/12/24 | 2/10/25 | 2/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.96x | 6.33x | 27.85x | -.--% | 18.85B | |
| 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 27.89x | 24.33x | 16.79x | 0.31% | 39.93B | |
| Weighted average by Cap. | 27.04x | 24.34x | 16.25x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MEDP Stock
- Valuation Medpace Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
